Injective, a Binance-incubated layer-1 blockchain backed by venture capital firms such as Jump Crypto and Pantera, has officially joined the Blockchain Association, a prominent pro-crypto advocacy group in the United States.
The announcement was made on March 25, highlighting Injective’s commitment to advancing blockchain-friendly policies. By becoming part of this influential group, Injective aligns itself with key industry players striving for regulatory clarity and mainstream adoption of cryptocurrency technologies.
Blockchain Association Advocates for Fair Policies and Strengthens Industry Collaboration
Established in 2018, the Blockchain Association has played a crucial role in advocating for the crypto industry. The organization represents a coalition of major blockchain firms, including Coinbase, Circle, Brevan Howard, and Pantera Capital.
Its mission is to push for policies that benefit both blockchain companies and investors, ensuring that the industry receives fair representation in legislative and regulatory discussions. Notably, the group has recently secured victories against the US Securities and Exchange Commission (SEC), further reinforcing its influence in shaping the crypto regulatory landscape.
Injective Joins Blockchain Association to Advocate for Pro-Crypto Policies in the USBy joining the Blockchain Association, Injective gains an opportunity to contribute to crucial policy discussions that shape the blockchain industry. The move allows Injective to play a more active role in influencing regulatory frameworks that impact decentralized finance (DeFi), stablecoins, and other emerging sectors. Additionally, the platform will benefit from strategic networking opportunities with industry leaders, allowing it to collaborate with major players in the crypto space.
Injective Supports Web3 Growth While Strengthening the US Crypto Industry
The Blockchain Association’s efforts span multiple sectors within the blockchain space, including DeFi, non-fungible tokens (NFTs), and real-world asset tokenization. As a blockchain committed to Web3 innovations, Injective sees this partnership as an opportunity to contribute to making the US a global leader in cryptocurrency adoption. The push for clearer regulations and greater mainstream acceptance of blockchain technology is expected to strengthen the overall ecosystem, benefiting companies, investors, and users alike.
Following the announcement, INJ, the native token of the Injective ecosystem, saw a slight price increase. At the time of writing, INJ was trading around $10.71, with bullish momentum indicating the potential for further gains.
Investors reacted positively to Injective’s strategic move, acknowledging the long-term advantages of its participation in regulatory discussions. The collaboration with the Blockchain Association strengthens Injective’s position within the industry, enhancing its influence and paving the way for sustained growth in the rapidly evolving crypto sector.